Literature DB >> 19056444

Basal and stimulus-induced cytokine expression is selectively impaired in peripheral blood mononuclear cells of newborn foals.

Tong Liu1, Jessica Nerren, Mei Liu, Ronald Martens, Noah Cohen.   

Abstract

Neonates are thought to be generally deficient in production of Th-1-associated cytokines at birth, and thereby more susceptible to bacterial infections. Using neonatal foals as a model, this study examined the age-dependent maturation of both basal and stimulus-induced immune responses, as reflected by the expression of a panel of Th-1-associated and pro-inflammatory cytokines. Results showed that although the basal production of IFN-gamma and IL-6 was impaired (P<0.05) in PBMCs of neonatal foals at birth, the basal production of IL-8, IL-12(p35/p40) and IL-23(p19/p40) were either in excess of or comparable to that of older foals. In response to Rhodococcus equi and CpG-ODN stimulation in vitro, PBMCs of neonatal foals showed increased (P<0.05) expression of IFN-gamma and IL-6, and preferentially increased expression of either IL-23(p19/p40) with R. equi stimulation or IL-12(p35/p40) with CpG-ODN stimulation. The magnitude of these stimulus-induced responses (except for IL-23p19), were significantly (P<0.05) less for newborn foals than for older foals. The selective impairment of age-dependent basal and stimulus-induced cytokine expression by newborn foals may reflect the different functional state of various TLR pathways in newborns, and be directly associated with their age-dependent susceptibility to infection. Our results indicate that CpG-ODNs can selectively stimulate deficient cytokines (P<0.05) from PBMCs in newborn foals in vitro, suggesting immunoprophylactic or therapeutic potential of CpG-ODNs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19056444     DOI: 10.1016/j.vaccine.2008.11.040

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  13 in total

1.  Early development of cytotoxic T lymphocytes in neonatal foals following oral inoculation with Rhodococcus equi.

Authors:  Seth P Harris; Melissa T Hines; Robert H Mealey; Debra C Alperin; Stephen A Hines
Journal:  Vet Immunol Immunopathol       Date:  2011-03-21       Impact factor: 2.046

2.  IgE-Binding Monocytes Have an Enhanced Ability to Produce IL-8 (CXCL8) in Animals with Naturally Occurring Allergy.

Authors:  Elisabeth M Larson; Susanna Babasyan; Bettina Wagner
Journal:  J Immunol       Date:  2021-05-05       Impact factor: 5.422

3.  Intranasal treatment with CpG-B oligodeoxynucleotides protects CBA mice from lethal equine herpesvirus 1 challenge by an innate immune response.

Authors:  Seong K Kim; Akhalesh K Shakya; Dennis J O'Callaghan
Journal:  Antiviral Res       Date:  2019-06-25       Impact factor: 5.970

4.  Interferon-gamma, interleukin-4 and interleukin-10 production by T helper cells reveals intact Th1 and regulatory TR1 cell activation and a delay of the Th2 cell response in equine neonates and foals.

Authors:  Bettina Wagner; Alexandra Burton; Dorothy Ainsworth
Journal:  Vet Res       Date:  2010-04-09       Impact factor: 3.683

5.  Failure of a VapA/CpG oligodeoxynucleotide vaccine to protect foals against experimental Rhocococcus equi pneumonia despite induction of VapA-specific antibody and interferon-γ response.

Authors:  Katharina L Lohmann; A Marianela Lopez; Stephen T Manning; Fernando J Marques; Robert Brownlie; Andrew L Allen; Anna E Sangster; George Mutwiri; Volker Gerdts; Andrew Potter; Hugh G G Townsend
Journal:  Can J Vet Res       Date:  2013-07       Impact factor: 1.310

6.  Intramuscular administration of a synthetic CpG-oligodeoxynucleotide modulates functional responses of neutrophils of neonatal foals.

Authors:  Noah D Cohen; Jessica R Bourquin; Angela I Bordin; Kyle R Kuskie; Courtney N Brake; Kaytee B Weaver; Mei Liu; M Julia B Felippe; Michael H Kogut
Journal:  PLoS One       Date:  2014-10-15       Impact factor: 3.240

7.  Effects of orally administered galacto-oligosaccharides on immunological parameters in foals: a pilot study.

Authors:  Johannes Cornelis Vendrig; Luc Edgar Coffeng; Johanna Fink-Gremmels
Journal:  BMC Vet Res       Date:  2014-11-19       Impact factor: 2.741

8.  Nanoparticulate CpG immunotherapy in RAO-affected horses: phase I and IIa study.

Authors:  J Klier; B Lehmann; S Fuchs; S Reese; A Hirschmann; C Coester; G Winter; H Gehlen
Journal:  J Vet Intern Med       Date:  2015-01       Impact factor: 3.333

9.  Age-related changes following in vitro stimulation with Rhodococcus equi of peripheral blood leukocytes from neonatal foals.

Authors:  Priyanka Kachroo; Ivan Ivanov; Ashley G Seabury; Mei Liu; Bhanu P Chowdhary; Noah D Cohen
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

10.  Effects of Separate and Concomitant TLR-2 and TLR-4 Activation in Peripheral Blood Mononuclear Cells of Newborn and Adult Horses.

Authors:  Johannes Cornelis Vendrig; Luc Edgar Coffeng; Johanna Fink-Gremmels
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.